Results 261 to 270 of about 1,077,211 (296)
Some of the next articles are maybe not open access.
Individual patient risk assessment and cost–benefit analysis of patiromer in AMBER
Lancet, The, 2020Iain M Macintyre
exaly
Approvals in 2016: cost–benefit challenges of new anticancer agents
Nature Reviews Clinical Oncology, 2017Philip Savage
exaly

